Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Key residues in the nicotinic acetylcholine receptor β2 subunit contribute to α-conotoxin LvIA binding.
Zhangsun D, Zhu X, Wu Y, Hu Y, Kaas Q, Craik DJ, McIntosh JM, Luo S.
???displayArticle.abstract???
α-Conotoxin LvIA (α-CTx LvIA) is a small peptide from the venom of the carnivorous marine gastropod Conus lividus and is the most selective inhibitor of α3β2 nicotinic acetylcholine receptors (nAChRs) known to date. It can distinguish the α3β2 nAChR subtype from the α6β2* (* indicates the other subunit) and α3β4 nAChR subtypes. In this study, we performed mutational studies to assess the influence of residues of the β2 subunit versus those of the β4 subunit on the binding of α-CTx LvIA. Although two β2 mutations, α3β2[F119Q] and α3β2[T59K], strongly enhanced the affinity of LvIA, the β2 mutation α3β2[V111I] substantially reduced the binding of LvIA. Increased activity of LvIA was also observed when the β2-T59L mutant was combined with the α3 subunit. There were no significant difference in inhibition of α3β2[T59I], α3β2[Q34A], and α3β2[K79A] nAChRs when compared with wild-type α3β2 nAChR. α-CTx LvIA displayed slower off-rate kinetics at α3β2[F119Q] and α3β2[T59K] than at the wild-type receptor, with the latter mutant having the most pronounced effect. Taken together, these data provide evidence that the β2 subunit contributes to α-CTx LvIA binding and selectivity. The results demonstrate that Val(111) is critical and facilitates LvIA binding; this position has not previously been identified as important to binding of other 4/7 framework α-conotoxins. Thr(59) and Phe(119) of the β2 subunit appear to interfere with LvIA binding, and their replacement by the corresponding residues of the β4 subunit leads to increased affinity.
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009, Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed Antil-Delbeke,
Molecular determinants by which a long chain toxin from snake venom interacts with the neuronal alpha 7-nicotinic acetylcholine receptor.
2000,
Pubmed Armishaw,
Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.
2010,
Pubmed Arredondo,
Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells.
2005,
Pubmed Azam,
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.
2009,
Pubmed Azam,
Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.
2005,
Pubmed
,
Xenbase Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase Celie,
Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.
2005,
Pubmed
,
Xenbase Corringer,
Nicotinic receptors at the amino acid level.
2000,
Pubmed Dani,
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
2007,
Pubmed D'hoedt,
Nicotinic acetylcholine receptors: an overview on drug discovery.
2009,
Pubmed Duan,
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.
2003,
Pubmed Dutertre,
Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors.
2004,
Pubmed Dutertre,
Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase Garza,
Expression of nicotinic acetylcholine receptors and subunit messenger RNAs in the enteric nervous system of the neonatal rat.
2009,
Pubmed Harvey,
Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors.
1997,
Pubmed
,
Xenbase Jensen,
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
2005,
Pubmed Lebbe,
Conotoxins targeting nicotinic acetylcholine receptors: an overview.
2014,
Pubmed Lewis,
Conus venom peptide pharmacology.
2012,
Pubmed Luo,
A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
2014,
Pubmed
,
Xenbase Luo,
Single-residue alteration in alpha-conotoxin PnIA switches its nAChR subtype selectivity.
1999,
Pubmed
,
Xenbase Muttenthaler,
Structure-activity studies on alpha-conotoxins.
2011,
Pubmed Poorthuis,
Nicotinic acetylcholine receptors controlling attention: behavior, circuits and sensitivity to disruption by nicotine.
2013,
Pubmed Posadas,
Nicotinic receptors in neurodegeneration.
2013,
Pubmed Pronk,
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.
2013,
Pubmed Quik,
Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
2005,
Pubmed Rahman,
Nicotinic receptors as therapeutic targets for drug addictive disorders.
2013,
Pubmed Rossman,
The physiology of the nicotinic acetylcholine receptor and its importance in the administration of anesthesia.
2011,
Pubmed Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed Schaal,
Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.
2014,
Pubmed Shen,
Roles of nicotinic acetylcholine receptors in stem cell survival/apoptosis, proliferation and differentiation.
2013,
Pubmed Shiembob,
Determinants of alpha-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit.
2006,
Pubmed Somm,
Nicotinic cholinergic signaling in adipose tissue and pancreatic islets biology: revisited function and therapeutic perspectives.
2014,
Pubmed Sun,
Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis.
1991,
Pubmed Tsuneki,
Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle.
1995,
Pubmed Wallace,
Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex.
2013,
Pubmed Yakel,
Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease.
2013,
Pubmed Yu,
Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.
2011,
Pubmed Yu,
Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
2013,
Pubmed